DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECCMBINANT DNA ADVISORY CCMMITTEE 
MINUTES OF MEETING 1 
SEPTEMBER 19, 1983 
The Recombinant CNA Advisory Committee (RAC) was convened for its twenty-eighth 
meeting at 9:00 a.m. on September 19, 1983, in Building 1, Wilson Hall, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. Mr. Robert 
Mitchell (Acting Chair), Attorney at Law in California, presided. In accordance 
with Public Law 92-463, the meeting was open to the public from 9:00 a.m. to 
10:30 a.m. and from 1:50 p.m. to 3:45 p.m. The meeting was closed to the public 
from 10:30 a.m. to 12:45 p.m. for review of proposals involving proprietary 
information. The following were present for all or part of the neeting: 
Conmittee members: 
Roys ton Clowes 
L. Albert Daloz 
David Friedman 
Susan Gottesman 
John Harvin 
Wolfgang Joklik 
Arthur Lardy 
Myron Levine 
Gerard McGarrity 
John McGonigle 
A Committee roster is attached (Attachment I). 
Ad hoc consultants: 
Mark Mills 
Robert Mitchell 
Mark Saginor 
Pieter Wensink 
William J. Gartland, Jr. 
(Executive Secretary) 
Ann Vidaver, University of Nebraska 
LeRoy Walters, Kennedy Institute 
Non-voting members: 
Morris Levin, Environmental Protection Agency 
Henry Miller, Food and Drug Administration 
Marvin Rogul, Environmental Protection Agency 
Sue Ttolin, Department of Agriculture 
William Walsh, Department of State 
1 The RAC is advisory to the NIH, and its recommendations should not be con- 
sidered as final or accepted. NIH action on many of these recommendations 
was published in the Federal Register on November 23, 1983 (48 FR 53056). 
The Office of Recombinant CNA Activities should be consulted for NIH policy 
on specific issues. 
